Biocept
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Biocept's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 58% to $25,858,000. Profit margin reached -124%. Total operating expenses were $29,401,000.

Profit Margin

Biocept, Inc. (NASDAQ:BIOC): Profit margin
2013 134.24K -9.23M -6877.86%
2014 133.41K -15.86M -11892.25%
2015 609.90K -16.94M -2779.03%
2016 3.22M -18.39M -570.86%
2017 5.06M -21.61M -426.42%
2018 3.25M -24.57M -755.98%
2019 5.52M -24.61M -445.23%
2020 27.46M -17.04M -62.06%
2021 61.24M -2.82M -4.61%
2022 25.85M -32.08M -124.09%

BIOC Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
25.85M61.24M27.46M5.52M3.25M5.06M3.22M609.90K133.41K134.24K
Cost of revenue
28.44M37.76M21.33M10.97M10.05M9.34M6.92M4.59M2.17M2.32M
Gross profit
-2.58M23.48M6.12M-5.44M-6.80M-4.27M-3.69M-3.98M-2.03M-2.19M
Operating exp.
Research and development
6.16M4.96M5.22M4.69M4.46M3.36M2.71M2.85M4.49M3.08M
Selling and marketing
7.12M8.32M6.39M5.94M5.91M6.34M5.05M3.88M2.13M148.90K
Total operating expenses
29.40M25.89M21.59M17.60M17.45M16.89M14.32M12.42M11.83M5.74M
Operating income
-31.98M-2.40M-15.46M-23.05M-24.25M-21.17M-18.02M-16.41M-13.87M-7.94M
Other income (expenses), net
-229K-290K-2.33M-2.08M-310.97K-431.40K153.64K-537.11K-1.99M782.11K
Income before tax
-32.21M-2.69M-17.80M-25.13M-24.56M-21.60M-18.39M-16.94M-15.86M-9.23M
Income tax expense
-125K125K-764.58K-523.33K1.88K7.62K2.05K1.60K1.50K800
Net income
-32.08M-2.82M-17.04M-24.61M-24.57M-21.61M-18.39M-16.94M-15.86M-9.23M
Earnings per share
Basic EPS
-56.78-5.73-43.16-357.54-2.63K-7.07K-17.29K-23.28K-96.74K-55.28K
Diluted EPS
-56.78-5.73-43.16-357.41-2.63K-7.07K-17.29K-23.28K-96.74K-55.28K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source